During the past decade, Endocrinology, Internal Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Endocrinology, Internal Medicine" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Endocrinology, Internal Medicine" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Endocrinology, Internal Medicine" in a lesser frequency.

Most popular intervention types in "Endocrinology, Internal Medicine" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab 40mg q2w" (1 trials), "Olokizumab" (1 trials), "Olokizumab 64mg q2w" (1 trials), "Olokizumab 64mg q4w" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Endocrinology, Internal Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Endocrinology, Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Endocrinology, Internal Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Endocrinology, Internal Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".